Literature DB >> 8849678

p42 MAPK phosphorylates 80 kDa MARCKS at Ser-113.

D C Schönwasser1, R H Palmer, T Herget, P J Parker.   

Abstract

It is demonstrated here that p42 MAPKinase (p42 MAPK) phosphorylates the Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS) at Ser-113. In permeabilised Swiss 3T3 cells activation of protein kinase C (PKC) leads to p42 MAPK activation, but only the protein kinase C sites in MARCKS become phosphorylated and not Ser-113. The mitogen platelet-derived growth factor (PDGF) elicits the same response. These results demonstrate that while Ser-113 is a substrate for p42 MAPK in vitro and can be phosphorylated in vivo as shown by Taniguchi et al. [(1994) J. Biol. Chem. 269, 18299-18302], its phosphorylation is not subject to acute regulation by p42 MAPK in Swiss 3T3 cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8849678     DOI: 10.1016/0014-5793(96)00991-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  The myristoylated alanine-rich C kinase substrate differentially regulates kinase interacting with stathmin in vascular smooth muscle and endothelial cells and potentiates intimal hyperplasia formation.

Authors:  Dan Yu; Ramkishore Gernapudi; Charles Drucker; Rajabrata Sarkar; Areck Ucuzian; Thomas S Monahan
Journal:  J Vasc Surg       Date:  2019-03-28       Impact factor: 4.268

2.  c-Jun N-terminal kinase phosphorylation of MARCKSL1 determines actin stability and migration in neurons and in cancer cells.

Authors:  Benny Björkblom; Artur Padzik; Hasan Mohammad; Nina Westerlund; Emilia Komulainen; Patrik Hollos; Lotta Parviainen; Anastassios C Papageorgiou; Kristiina Iljin; Olli Kallioniemi; Markku Kallajoki; Michael J Courtney; Mats Mågård; Peter James; Eleanor T Coffey
Journal:  Mol Cell Biol       Date:  2012-07-02       Impact factor: 4.272

3.  Development-associated myristoylated alanine-rich C kinase substrate phosphorylation in rat brain.

Authors:  Hideo Hamada; Yun-Ling Zhang; Akiko Kawai; Fang Li; Yasuhide Hibino; Yutaka Hirashima; Masanori Kurimoto; Nakamasa Hayashi; Ichiro Kato; Shunro Endo; Koichi Hiraga
Journal:  Childs Nerv Syst       Date:  2003-01-30       Impact factor: 1.475

4.  MARCKS silencing differentially affects human vascular smooth muscle and endothelial cell phenotypes to inhibit neointimal hyperplasia in saphenous vein.

Authors:  Thomas S Monahan; Nicholas D Andersen; Michelle C Martin; Junaid Y Malek; Gautam V Shrikhande; Leena Pradhan; Christiane Ferran; Frank W LoGerfo
Journal:  FASEB J       Date:  2008-10-21       Impact factor: 5.191

5.  Apical accumulation of MARCKS in neural plate cells during neurulation in the chick embryo.

Authors:  F R Zolessi; C Arruti
Journal:  BMC Dev Biol       Date:  2001-04-24       Impact factor: 1.978

6.  A novel effect of MARCKS phosphorylation by activated PKC: the dephosphorylation of its serine 25 in chick neuroblasts.

Authors:  Andrea Toledo; Flavio R Zolessi; Cristina Arruti
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

7.  MARCKS Signaling Differentially Regulates Vascular Smooth Muscle and Endothelial Cell Proliferation through a KIS-, p27kip1- Dependent Mechanism.

Authors:  Dan Yu; George Makkar; Tuo Dong; Dudley K Strickland; Rajabrata Sarkar; Thomas Stacey Monahan
Journal:  PLoS One       Date:  2015-11-03       Impact factor: 3.240

Review 8.  X MARCKS the spot: myristoylated alanine-rich C kinase substrate in neuronal function and disease.

Authors:  Jon J Brudvig; Jill M Weimer
Journal:  Front Cell Neurosci       Date:  2015-10-13       Impact factor: 5.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.